Abstract:Abstract Background There have been suggestions of an association between Chlamydia pneumoniae , chlamydial heat shock protein (Ch-hsp) 60 and human heat shock protein (h-hsp) 60 infection sero-status and development of secondary cardiovascular events. Patients with diabetes might be at higher risk since they are prone to infections. The objective of this study was to investigate prospectively the role of Chlamydia pneumoniae (CP), chlamydial heat shock protein (Ch-hsp) 60 and a possible intermediate role of human heat shock protein (h-hsp) 60 sero-status in the development of secondary cardiovascular disease (CVD) events in patients with coronary heart disease (CHD) under special consideration of diabetes mellitus. Methods Patients aged 30–70 undergoing an in-patient rehabilitation program after acute manifestation of coronary heart disease (International Classification of Disease, 9 th Rev. pos. 410–414) between January 1999 and May 2000 in one of two participating rehabilitation clinics in Germany were included in this analysis. Chlamydia pneumoniae (CP), chlamydial heat shock protein (Ch-hsp) 60 and human heat shock protein (h-hsp) 60 status at baseline were measured by serum immunoglobulin G and A antibodies. Secondary CVD events (myocardial infarction, stroke, and cardiovascular death) were recorded during a mean follow-up period of 33.5 months (response = 87%). Results Among the 1052 subjects 37.4% and 39.3% were sero-positive to CP IgA and IgG respectively, 22.2% were sero-positive to Ch-hsp 60 IgG and 8.4% were positive to h-hsp 60 IgG at baseline. During follow-up, secondary CVD events occurred among 71 (6.8%) participants. Occurrence of a secondary CVD event was more common among CP (IgA) and CP (IgG) sero-positive than among sero-negative patients (p-values 0.04 and 0.1, respectively). The risk of secondary CVD events was increased among patients with both a positive CP sero-status and diabetes compared to infection negative, non-diabetic patients and in general, sero-positivity added a hazard to diabetes. The interaction term between infection sero-status and diabetes was not statistically significant. We were not able to show an intermediate role of human heat shock protein (h-hsp) 60 sero-status in the development of secondary CVD events in patients with CHD. Conclusion Results from this cohort of 1052 patients with pre-existing CHD cannot exclude a possible moderate increase in risk of secondary CVD events among patients with a positive infection sero-status. However, our study showed no intermediate role of human heat shock protein (h-hsp) 60 sero-status in the development of secondary CVD events in patients with CHD. Larger studies or meta-analysis of multiple studies are needed to address the interaction between infection sero-status and diabetes with adequate power.

Association Between Chlamydia Pneumonia Infection and Coronary Atherosclerosis in Patients with Diabetes Mellitus Type 2

Changes of Th1/Th2 Cell Ratio in the Peripheral Blood of Patients with Both Coronary Heart Disease and Diabetes

The Study of Relationship Between Infection and Coronary Heart Disease

Change of High Sensitive CRP and WBC Count in Coronary Heart Disease Patients with Type 2 Diabetes

Changes of Pulse Wave Velocity in Patients with Coronary Artery Disease Combined with Diabetes Mellitus

Relationship Between Autoantibodies Against Oxidized Low-Density Lipoprotein and High-Sensitivity C-reactive Protein in Patients with Coronary Artery Disease

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

THE CORONARY ANGIOGRAPHY FEATURES AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CORONARY HEART DISEASE COMPLICATED TYPE 2 DIABETES MELLITUS

Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells in Healthy Control Subjects and Patients with Diabetes mellitus, Acute Coronary Syndrome, Stroke, and Arterial Hypertension

Correlations Between Chlamydophila Pneumoniae, Cytomegalovirus Infection and Carotid Atherosclerotic Plaque and Its Stability

The Relation Between Coronary Heart Disease and Chronic Infection of Microorganism

Study on correlation of Cytomegalovirus infection, endothelin and tumor necrosis factor with atherosclerosis in type 2 diabetes mellitus

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Correlation of Plasma Adipokines with Coronary Heart Disease and Diabetic Mellitus

The relationship between chronic obstructive pulmonary disease and Chlamydiae pneumoniae infection]

Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern

Potential Roles of Chlamydia Pneumoniae Infection in Coronary Atherosclerosis and Restenosis in Old Patients

Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus

Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study

Correlation Analysis of CPN, Hp, HCMV Pathogenic Microorganism Infection Status and Serum Inflammation Marker Level in Patients with Coronary Heart Disease

The clinical manifestations and coronary angiographic characteristics of patients with coronary heart disease and type 2 diabetes mellitus